Skip to content

Newsroom

type
year
Illustration image.png

Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo

12/4/2018 Press release
Illustration image.png

Orion Corporation: Managers' transactions - Agendum Oy

11/28/2018 Managers transactions
Illustration image.png

Orion Corporation: Managers' transactions - Mikael Silvennoinen

11/27/2018 Managers transactions
Illustration image.png

Orion Research Foundation grants million euros for research in 2019

11/1/2018 Press release
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

10/30/2018 Stock exchange release
Illustration image.png

Orion Corporation: Managers' transactions - Konsta Westerlund

10/30/2018 Managers transactions
Illustration image.png

Orion Corporation: Managers' transactions - Leevi Westerlund

10/30/2018 Managers transactions
Illustration image.png

Orion Corporation: Managers' transactions - Riikka Westerlund

10/30/2018 Managers transactions
Illustration image.png

Orion Corporation: Managers' transactions - Eija Ronkainen

10/26/2018 Managers transactions
Illustration image.png

Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland

10/24/2018 Press release
Illustration image.png

Orion Group Interim Report January-September 2018

10/24/2018 Stock exchange release
Illustration image.png

Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer - The primary endpoint was met

10/24/2018 Stock exchange release
Illustration image.png

Orion Corporation: Managers' transactions - Sydäntutkimussäätiö sr.

10/19/2018 Managers transactions
Illustration image.png

Publishing of Orion Corporation's Interim Report for January-September 2018 on 24 October 2018

10/10/2018 Press release
Illustration image.png

Changes in responsibility areas of the Orion Group Executive Management Board

9/19/2018 Stock exchange release
Illustration image.png

Creation of novel medicines and better patient care for the future in an ecosystem

9/17/2018 Press release
Illustration image.png

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

9/10/2018 Press release
Illustration image.png

Orion Group Half-Year Financial Report January-June 2018

7/18/2018 Stock exchange release